Bon Natural Life Ltd (BON) stock
BONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends September 30
$1.10−0.03 (-2.65%)
Close on Nov 13, 2026Market cap $8.94MP/E –Yield –
Bon Natural Life EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was -$0.72, down 117.4% from the year before. The highest annual figure on record is $124.92 in fiscal 2023.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$0.72 | -117.4% |
| FY2024 | Sep 30, 2024 | $4.14 | -96.7% |
| FY2023 | Sep 30, 2023 | $124.92 | +1581.3% |
| FY2022 | Sep 30, 2022 | $7.43 | +992.6% |
| FY2021 | Sep 30, 2021 | $0.68 | +17.2% |
| FY2020 | Sep 30, 2020 | $0.58 | +16.0% |
| FY2019 | Sep 30, 2019 | $0.50 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?